As the contented implicit the deaths of Gambian children which was blamed connected immoderate Indian cough syrups escalates, the World Health Organization (WHO) has said that it stands by its enactment of issuing an alert regarding the said medicine.
This occurs aft India notified the WHO that samples obtained from the Indian pharmaceutical concern Maiden Pharma, whose goods were implicated successful the deaths of children successful the Gambia, had been deemed to conscionable the indispensable specifications.
In a missive to the planetary wellness authorization dated December 13, India's drugs controller general, VG Somani, said that tests conducted connected samples of Maiden Pharma's products "have been recovered to beryllium complying with specifications". The missive besides said that samples were not contaminated with ethylene glycol and diethylene glycol arsenic alleged.
Talking to BBC via email, the wellness bureau said "WHO's mandate is to contented planetary alerts astir imaginable risks. WHO stands by the enactment taken," adding that "contaminated syrups are unsafe and should not beryllium successful immoderate medicine, ever".
WHO successful October said that its investigators had recovered "unacceptable" levels of the 2 chemicals successful Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup; cough syrups made by Maiden Pharmaceuticals, an Indian company.
These chemicals person been known to beryllium toxic and tin origin kidney damage.
In the missive addressed to WHO's manager of regularisation and prequalification Roderigo Gaspar, Somani claimed that the wellness agency's October connection connecting the deaths to the cough syrup made successful India had done "irreparable damage" to the nation's pharmaceutical proviso chain.
(With inputs from agencies)
WATCH WION LIVE HERE
You tin now constitute for wionews.com and beryllium a portion of the community. Share your stories and opinions with america here.
English (US)